Association of IL-6-174G>C and -572C>G polymorphisms with risk of young ischemic stroke patients

Gene

Volumn 539, Issue 2, 2014, Pages 258-262

  Xuan, Yang ^a   Lei, Feng ^a   Changjiang, Li ^b   Yu, Li ^c  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b Qingdao Tumor Hospital   (China)

^c Zibo Municipal Hospital Authorities Internal Medicine   (China)

Author keywords

Interleukin 6; Ischemic stroke; Polymorphism; Risk

Indexed keywords

INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; SMOKING;

INTERLEUKIN-6; ISCHEMIC STROKE; POLYMORPHISM; RISK;

ADULT; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; STROKE;

EID: 84896729940     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.01.054     Document Type: Article

References (41)

1. Acalovschi D., et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003, 34:1864-1869.
2. Balding J., et al. The IL-6G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir. J. Med. Sci. 2004, 173:200-203.
3. Chakraborty B., et al. Interleukin-6 gene -174G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India. J. Stroke Cerebrovasc. Dis. 2013, 22:683-689.
4. Chamorro A., et al. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovasc. Dis. 2005, 19:91-95.
5. Córdoba-Lanús E., et al. Association of IL-6 gene polymorphisms and COPD in a Spanish population. Respir. Med. 2008, 102:1805-1811.
6. Dichgans M., Markus H.S. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 2005, 2(36):2027-2031.
7. Fishman D., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
8. Flex A., et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004, 35:2270-2275.
9. Gao L.B., et al. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 2009, 30:295-299.
10. Greisenegger S., et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb. Res. 2003, 110:181-186.
11. Gu X.J., et al. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. Clin. Immunol. 2008, 127:298-302.
12. He M.X., et al. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol. Sci. 2010, 31:165-168.
13. Hollegaard M.V., Bidwell J.L. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 2006, 7(Supplement 3):269-276.
14. Hoshi T., et al. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis 2008, 197:326-332.
15. Humphries S.E., et al. The interleukin-6 174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 2001, 22:2243-2252.
16. Jia X., et al. Association between the interleukin-6 gene -572G/C and -597G/A polymorphisms and coronary heart disease in the Han Chinese. Med. Sci. Monit. 2010, 16:CR103-CR108.
17. Jia X.W., et al. Correlation of polymorphism in IL-6 gene promoter with BMI, inflammatory factors, and pathogenesis and progression of CHD. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007, 15:1270-1275.
18. Johnson C.J., et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke 1995, 26:46-51.
19. Lalouschek W., et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin. Chem. Lab. Med. 2006, 44:918-923.
20. Li J., et al. Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension. J. Interferon Cytokine Res. 2012, 32:542-547.
21. Lindsberg P.J., Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518-2532.
22. Ma Y., et al. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum. Immunol. 2011, 72:641-651.
23. Morgan L., et al. The interleukin-6 gene -174G[C and -572G[C promoter polymorphisms are related to cerebral aneurysms. J. Neurol. Neurosurg. Psychiatry 2006, 77:915-917.
24. Pola R., et al. Synergistic effect of -174G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003, 34:881-885.
25. Podgoreanu M.V., et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006, 114:I275-I281.
26. Revilla M., et al. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci. Lett. 2002, 324:29-32.
27. Shimizu K., et al. Association between inflammatory biomarkers and progression of intracranial large artery stenosis after ischemic stroke. J. Stroke Cerebrovasc. Dis. 2013, 22:211-217.
28. Smith C.J., et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4:2.
29. Strand M., et al. Polymorphisms at the osteoprotegerin and interleukin-6 genes in relation to first-ever stroke. Cerebrovasc. Dis. 2007, 24:418-425.
30. Terry C.F., et al. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 2000, 275:18138-18144.
31. Tong Y., et al. The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem. Biophys. Res. Commun. 2010, 391:481-485.
32. Tso A.R., et al. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 2007, 38:3070-3075.
33. Venti M., et al. Genetics of ischemic stroke. Clin. Exp. Hypertens. 2002, 24:531-534.
34. van der Spuy W.J., Pretorius E. Interrelation between inflammation, thrombosis, and neuroprotection in cerebral ischemia. Rev. Neurosci. 2012, 23:269-278.
35. Wu J., et al. Association between interleukin-16 polymorphisms and risk of coronary artery disease. DNA Cell Biol. 2011, 30:305-308.
36. Xue H., et al. The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus. Clin. Chim. Acta 2009, 403:223-225.
37. Yamada Y., et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1920-1925.
38. Yin Y.W., et al. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects. Gene 2013, 529:94-103.
39. Zhang G., et al. Association of interleukin-6-572G/C gene polymorphisms in the Cantonese population with intracranial aneurysms. J. Neurol. Sci. 2011, 306:94-97.
40. Zhang Z., et al. Association between Interleukin-1 gene single nucleotide polymorphisms and ischemic stroke classified by TOAST criteria in the Han population of northern China. Biomed. Res. Int. 2013, 2013:961039.
41. Ziganshina L.E., et al. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst. Rev. 2010, CD007026.